Phaseline

Targets › HIB

HIB: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Infectious disease.

Open in Phaseline: the race on HIB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
CanSino BiologicsLyophilized Haemophilus Influenzae Type b Conjugate Vaccine
Haemophilus influenzae type b polysaccharide conjugate vaccine
HIBPhase 1Haemophilus Influenzae Type B Infection–

Conditions

Haemophilus Influenzae Type B Infection (1)

Modalities

other (1)

Companies

CanSino Biologics (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.